Delirium, Dementia, Amnestic, Cognitive Disorders  >>  SAR228810  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SAR228810 / Sanofi
NCT01485302: Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients

Completed
1
48
Europe, RoW
SAR228810
Sanofi
Alzheimer's Disease
02/15
02/15

Download Options